Latest | F'cast | |
---|---|---|
Div Yield | 1.4% | |
Div Cover | 1.7 | |
Op Mrgn | 0.5% | |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | 40.6 | |
PEG | 0.2 | |
Pr/Revenue | 0.2 | |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | 10.7% | |
PBT | 81.1% | |
EPS | 174.0% | |
DPS | 1.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 152,922.00 | (3,372.00) | (1,261.00)¢ | n/a | n/a | n/a | 192.00¢ | 3.7% |
30-Jun-21 | 162,467.00 | 323.00 | 209.00¢ | 27.3 | n/a | n/a | 194.00¢ | 3.4% |
30-Jun-22 | 181,364.00 | (769.00) | (335.00)¢ | n/a | n/a | n/a | 196.00¢ | 3.7% |
30-Jun-23 | 204,979.00 | 663.00 | 127.00¢ | 74.5 | n/a | n/a | 198.00¢ | 2.1% |
30-Jun-24 | 226,827.00 | 1,201.00 | 348.00¢ | 28.3 | 0.2 | +174% | 200.00¢ | 2.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-25 | 223,115.17 | 2,693.40 | 796.02¢ | 17.7 | 0.1 | +129% | 204.53¢ | 0.0% |
30-Jun-26 | 242,659.70 | 3,041.51 | 897.06¢ | 15.8 | 1.2 | +13% | 208.28¢ | 0.0% |
30-Jun-27 | 260,602.72 | 3,280.73 | 994.27¢ | 14.2 | 1.3 | +11% | 208.50¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
New York sues big pharma firms over role in opio... | 24-Jan-2018 | ShareCast |
Device Maker to Cut 5% of Workers | 11-Aug-2010 | New York Times |
Cardinal Health Looks at Spinoff | 08-Aug-2008 | New York Times |
Cardinal Health Settles Shareholders' Suit | 01-Jun-2007 | New York Times |
Currency | US Dollars |
Share Price | $ 145.25 |
Change Today | $ 3.96 |
% Change | 2.80 % |
52 Week High | $147.27 |
52 Week Low | $93.74 |
Volume | 2,093,635 |
Shares Issued | 327.00m |
Market Cap | $47,497m |
Beta | 0.43 |
RiskGrade | 123 |
Strong Buy | 6 |
Buy | 6 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 17 |
Time | Volume / Share Price |
13:46 | 200 @ $145.25 |
13:46 | 100 @ $145.31 |
13:45 | 100 @ $145.35 |
13:45 | 200 @ $145.29 |
13:45 | 100 @ $145.28 |
You are here: research